Your Fertility Appointment Today to Start Your Family Tomorrow


You are here

Fertility Tests

Fertility doctors use a range of blood tests and surgical tests to investigate fertility issues.

Fertility Tests Articles

The AMH test (Anti-Mullerian Hormone) is a blood test to help the fertility doctor assess the woman's ovarian reserve. The test measures the levels of AMH in a woman's blood and is helpful in determining whether a woman has premature ovarian aging (diminished ovarian reserve) or premature ovarian failure.

If blood tests and other diagnostic tests do not determine the cause of your infertility, your health care professional may suggest one or two surgical tests to try to diagnose or treat the problem. One test lets the doctor see inside the uterus and the other shows the outside of the uterus, the ovaries, and fallopian tubes.

What it FSH? What is High FSH? FSH is a hormone produced by the pituitary gland. FSH causes follicles - the sacs in your ovaries that contain eggs - to grow. FSH is the primary hormone responsible for producing eggs. In men, FSH is necessary for sperm production. When Should You Have FSH Levels Checked?

Fertility Tests Videos

Who Might Consider Uterine Lavage?

Uterine lavage may provide a genetic testing option for women who may be carriers of diseases that can be inherited by their children, says Dr. Steven Nakajima, of Stanford Medicine Fertility and Reproductive Health. She must have open fallopian tubes, and can get pregnant naturally or in a stimulated cycle or with IUI.

What is Uterine Lavage?

With uterine lavage, a blastocyst that was created in vivo (in the body) is removed to for genetic testing, explains Steven Nakajima, MD, at Stanford Medicine Fertility and Reproductive Health. It could provide an alternative to genetic testing that currently is only available with IVF.

Is Uterine Lavage an Option for Genetic Screening?

With uterine lavage an embryo is created in vivo (in the body), and then removed to for genetic testing. This would allow for a non-IVF diagnosis of potential genetic diseases in embryos, explains Steven Nakajima, MD, at Stanford Medicine Fertility and Reproductive Health